Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitaxentan for Airway Remodeling in Severe Asthma
NCT01050491Phase 2Terminated
- Sponsor
- Inserm
- Start
- Nov 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitaxsentan in asthma, sponsored by Inserm. Started Nov 2009; status: terminated.
02
Drugs
sitaxsentan
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01050491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050491.